Anne Samuel

Stock Analyst at JP Morgan

(2.56)
# 2,354
Out of 5,032 analysts
70
Total ratings
53.49%
Success rate
1.56%
Average return

Stocks Rated by Anne Samuel

HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125$126
Current: $91.48
Upside: +37.74%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274$290
Current: $283.73
Upside: +2.21%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23$25
Current: $19.34
Upside: +29.27%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63$60
Current: $67.57
Upside: -11.20%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232$177
Current: $204.55
Upside: -13.47%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44$36
Current: $29.90
Upside: +20.40%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13$12
Current: $7.53
Upside: +59.36%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27$28
Current: $22.29
Upside: +25.62%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21$19
Current: $28.00
Upside: -32.14%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19$21
Current: $25.26
Upside: -16.86%
Maintains: Overweight
Price Target: $10$13
Current: $3.05
Upside: +326.23%
Maintains: Overweight
Price Target: $24$27
Current: $36.98
Upside: -26.99%
Downgrades: Underweight
Price Target: $7$5
Current: $2.87
Upside: +74.22%